Neuromyelitis Optica Spectrum Disorder: Novel Therapeutic Landscape and Impact on Treatment Paradigms

Release Date: 7/28/2022
Expiration Date: 7/27/2023

Provider Statement

This continuing education activity is provided by

Support Statement

This activity is supported by an educational grant from Horizon Therapeutics USA, Inc.

There is no non-commercial support for this activity.

Education activities are distinguished as separate from endorsement of commercial products. When commercial products are displayed, participants will be advised that accredited status as a provider refers only to its continuing education activities and does not imply ANCC Commission on Accreditation endorsement of any commercial products.

Target Audience

The intended audience for this activity is neurologists, ophthalmologists, nurses, pharmacists, physician assistants, nurse practitioners, and other health care professionals involved in the management of patients with or at risk for NMOSD.

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

Assess the impact of NMOSD on patient quality of life.
Evaluate best practices for the early detection and differential diagnosis of NMOSD.
Examine current NMOSD treatments for their mechanisms of action, modes of administration, and clinical evidence regarding their safety and efficacy,
Review interprofessional approaches to acute and long-term care of patients with NMOSD.

Activity Chair

Prem S. Subramanian, MD, PhD
Professor of Ophthalmology, Neurology, and Neurosurgery
University of Colorado School of Medicine
Vice Chair for Academic Affairs
Division Head, Neuro-Ophthalmology
University of Colorado Sue Anschutz-Rodgers Eye Center
Aurora, CO

Faculty

Rachel Brandstadter, MD
Assistant Professor of Clinical Neurology
Perelman School of Medicine
University of Pennsylvania
Corporal Michael J Crescenz VA Medical Center
Philadelphia, PA

Benjamin M. Greenberg, MD, MHS, FANA, FAAN, CRND
Distinguished Teaching Professor
Vice Chair for Clinical and Translational Research
Department of Neurology
Director, Perot Foundation Neurosciences Translational Research Center
O’Donnell Brain Institute
University of Texas Southwestern
Dallas, TX

Megan R. Weigel, DNP, ARNP-c, MSCN
Advanced Registered Nurse Practitioner
First Coast Integrative Medicine and Universal Neurological Care
Jacksonville, FL

Planners and Reviewers

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Jennifer Frederick, PharmD, BCPS
Barbara A. Niedz, PhD, RN, CPHQ

Accreditation

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Vindico Medical Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Vindico Medical Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to satisfy the Lifelong Learning and Self-Assessment requirements for the American Board of Ophthalmology’s Continuing Certification program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting credit.

Upon successful completion, learners who opt-in by providing their ABO ID and DOB (MM/DD) will earn Continuing Certification credits equivalent to the amount of CME credits claimed for the activity.

Vindico Medical Education will provide a maximum of 1.25 contact hours for nurses. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

This program is acceptable for 1.25 contact hour of Accreditation Council for Pharmacy Education (ACPE) Continuing Education Credit. The ACPE Universal Program Number is 0482-0000-22-028-H01-P, effective 7/28/2022. This is a knowledge-based activity and there is no fee to attend.

Vindico Medical Education will provide pharmacist credits claimed information directly to the ACPE through CPE Monitor within 30 days.

Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners Certification Board (AANPCB). AANPCB will accept AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME. American

Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 1.25 hours credit for completing this program.

This enduring material is approved for 1 year from the date of original release, July 28, 2022, to July 27, 2023.

How to Participate in This Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 of the 4 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate, Contact Hours certificate, or CPE Statement of Credit.

Disclosures

Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Activity Chair and Faculty report the following relevant financial relationship(s)

Rachel Brandstadter, MD
Consultant: Alexion

Benjamin M. Greenberg, MD, MHS, FANA, FAAN, CRND
Consultant: Alexion, Genentech/Roche, Horizon

Prem S. Subramanian, MD, PhD
Consultant: Horizon
Independent Research Contractor: Horizon

Megan R. Weigel, DNP, ARNP-c, MSCN
Consultant: Horizon
Speaker Contracted by Ineligible Company: Horizon

Planners and Reviewers report the following relevant financial relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Jennifer Frederick, PharmD, BCPS
No relevant financial relationships to disclose.

Barbara A. Niedz, PhD, RN, CPHQ
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relevant financial relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. © 2022 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at [email protected]